Vera Therapeutics (VERA)
(Delayed Data from NSDQ)
$26.96 USD
+0.82 (3.14%)
Updated Sep 25, 2025 04:00 PM ET
After-Market: $26.99 +0.03 (0.11%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth D Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
VERA 26.96 +0.82(3.14%)
Will VERA be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for VERA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for VERA
Wall Street Analysts Think Vera Therapeutics (VERA) Could Surge 27.26%: Read This Before Placing a Bet
VERA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for VERA
VERA forms NR7 on September 25
VERA forms Stochastic Sell Signal on September 23
VERA forms Slingshot Bullish on September 23
VERA forms Upper Bollinger Band Walk on September 19
180 Bullish Setup appears for VERA after 7.33% move